(Q33310987)

25 July 2017

title

Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary). (English)

1 reference

25 July 2017

1 reference

Marie-Christine Mathieu

5

object named as

Marie-Christine Mathieu

0 references

Karim Fizazi

2

object named as

Karim Fizazi

1 reference

25 July 2017

Delphine Lequin

1

1 reference

25 July 2017

Saloua Toujani

3

1 reference

25 July 2017

Sylvie Souquère

4

1 reference

25 July 2017

Marie-Christine Mathieu

5

1 reference

25 July 2017

Pierre Hainaut

6

1 reference

25 July 2017

Alain Bernheim

7

1 reference

25 July 2017

Françoise Praz

8

1 reference

25 July 2017

Pierre Busson

9

1 reference

25 July 2017

language of work or name

English

0 references

publication date

18 December 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

7

1 reference

25 July 2017

page(s)

225

1 reference

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

25 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Cancer of unknown primary site: missing primary or missing biology?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Sunitinib: from rational design to clinical efficacy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Arrayed primer extension resequencing of mutations in the TP53 tumor suppressor gene: comparison with denaturing HPLC and direct sequencing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Metastases in carcinoma; analysis of 1000 autopsied cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Altered adhesion properties and alphav integrin expression in a cisplatin-resistant human ovarian carcinoma cell line.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

p53 gene mutation spectrum in human unknown primary tumors.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Establishing germ cell origin of undifferentiated tumors by identifying gain of 12p material using comparative genomic hybridization analysis of paraffin-embedded samples.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-225

Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-225

Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-225

The IARC TP53 database: new online mutation analysis and recommendations to users

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-225

Switching benchmarks in cancer of unknown primary: from autopsy to microarray

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Clinical and immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18088404

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18088404

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-7-225

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference